FDA Approves Two Hologic HPV Tests
Avero Diagnostics is proud to announce to its clients that Hologic received approval from the FDA for two Human Papillomavirus HPV tests; Cervista HPV HR and Cervista HPV 16/18. The Cervista HPV HR is the first FDA approved high-risk HPV test in a decade. The Cervista HPV 16/18 is the First HPV DNA genotyping test approved by the FDA.
Avero Diagnostics has offered these tests as an ASR for the past two years. We felt that the Cervista HPV was a better test for Gynecologists to use in identifying patients with High Risk HPV. If you search the "News" section of the Avero Diagnostics website you will find two articles discussing Cervista HPV tests and copies of two posters presented at the 2008 ASC meeting.
For more information on the FDA approval please see the attached Press Release by Hologic.
Download (27.83 KB PDF)